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ABSTRACT
RNA interference (RNAi) targeted towards viral
mRNAs is widely used to block virus replication in
mammalian cells. The specific antiviral RNAi
response can be induced via transfection of
synthetic small interfering RNAs (siRNAs) or via
intracellular expression of short hairpin RNAs
(shRNAs). For HIV-1, both approaches resulted in
profound inhibition of virus replication. However,
the therapeutic use of a single siRNA/shRNA
appears limited due to the rapid emergence of
RNAi-resistant escape viruses. These variants con-
tain deletions or point mutations within the target
sequence that abolish the antiviral effect. To avoid
escape from RNAi, the virus should be simulta-
neously targeted with multiple shRNAs.
Alternatively, long hairpin RNAs can be used from
which multiple effective siRNAs may be produced.
In this study, we constructed extended shRNAs
(e-shRNAs) that encode two effective siRNAs
against conserved HIV-1 sequences. Activity
assays and RNA processing analyses indicate that
the positioning of the two siRNAs within the hairpin
stem is critical for the generation of two functional
siRNAs. E-shRNAs that are efficiently processed
into two effective siRNAs showed better inhibition
of virus production than the poorly processed
e-shRNAs, without inducing the interferon
response. These results provide building principles
for the design of multi-siRNA hairpin constructs.
INTRODUCTION
RNA interference (RNAi) is an evolutionarily conserved
mechanism in which double stranded RNA (dsRNA)
induces sequence-speciﬁc gene silencing (1). RNAi is
initiated by the RNase III-like enzyme Dicer that
processes dsRNAs into 21–25bp dsRNAs called small
interfering RNAs (siRNAs) (2–4). Subsequently, the
siRNA is incorporated into the RNA-induced silencing
complex (RISC), which uses one strand of the siRNA
as a guide to target the complementary mRNA for
cleavage (4). In mammalian cells, RNAi can be induced
via transfection of synthetic siRNAs (5) or DNA vectors
for intracellular expression of short hairpin RNAs
(shRNAs) (6).
RNAi induction via transfection of siRNAs or via
stable expression of shRNAs has been shown to be highly
eﬀective in inhibiting HIV-1 (7–11). However, HIV-1 can
escape from RNAi by introduction of nucleotide substitu-
tions or deletions in the siRNA target sequence (12–14).
In addition, HIV-1 can also escape from RNAi-mediated
inhibition through mutations that alter the local RNA
secondary structure (14). To reduce the chance of escape,
the virus should be targeted simultaneously with multiple
highly eﬃcient siRNAs. We recently identiﬁed a large set
of potent shRNA inhibitors against diﬀerent highly
conserved HIV-1 sequences (15), which can be used to
target multiple sites. There are several ways to express
multiple eﬀective siRNAs. One possibility is the insertion
of multiple shRNA-expression cassettes in a viral vector.
However, repeats of the same regulatory sequences,
e.g. the H1 polymerase III promoter, may cause genetic
instability and reduced titer of the vector system
(Ter Brake and Berkhout, submitted for publication).
Ideally, the expression of multiple antiviral shRNAs
should be coordinated by putting them in a single
transcript. Another possibility is to use long hairpin
RNAs (lhRNAs), from which multiple siRNAs can be
produced. Several reports described eﬃcient RNAi
induction by lhRNAs against human deﬁciency virus 1
(16,17), hepatitis C virus (18,19) and hepatitis B virus (20).
Importantly, intracellular lhRNA expression does not
seem to induce non-speciﬁc type 1 interferon (IFN)
responses in cells, which may occur when dsRNA longer
than 30bp is introduced in mammalian cells (21,22).
Induction of a type I IFN response will lead to non-
sequence speciﬁc degradation of mRNAs. However,
recent studies showed that smaller duplexes can also
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dependent.
To learn how to design eﬀective extended hairpin RNAs
(e-shRNAs), from which several eﬀective siRNAs can be
produced, we constructed a series of antiviral e-shRNA
constructs and examined their silencing activities on
luciferase reporters and HIV-1. We determined the
minimal hairpin stem length to produce two active
siRNAs. Furthermore, we demonstrated that siRNA
activity correlates with proper processing of the
e-shRNAs. Importantly, we showed that extended hairpin
RNA transcripts are highly eﬃcient in inhibiting HIV-1
production, without induction of the IFN response in
cells. These results provide building principles for the
design of multi-siRNA hairpin constructs for durable
inhibition of escape-prone RNA viruses.
MATERIAL AND METHODS
DNA constructs
Hairpin RNA constructs were made by annealing of
complementary oligonucleotides and inserting them into
the BglII and HindIII site of the pSUPER vector (6). The
sequences of the oligonucleotides used are listed in
Supplementary Table 1. siRNA sequences for construct-
ing the hairpin construct targeting the luciferase gene
(GL3) were described previously (5,25). Luciferase report-
ers containing 50nt of the HIV-1 gag, pol and nef gene in
the 30 UTR were made using annealed oligonucleotides,
which were ligated between the EcoRI and PstI sites of the
ﬁreﬂy luciferase vector pGL3 (Promega). The same
procedure was used for construction of the luciferase
reporter with a 19nt gag target. The plasmid encoding the
HIV-1 isolate LAI (26) was used to produce virus in
transfected 293T cells.
For ampliﬁcation of plasmids, Escherichia coli GT116
cells were transformed with the constructs by electropora-
tion with Gene Pulser II, 25mF, 200V and 2.5kV. The
bacteria were grown in Luria Broth medium containing
100mg/ml ampicillin by shaking at 378C or on LB agar
plates containing 100mg/ml ampicillin at 378C. Plasmids
were isolated using the Qiagen Maxiprep or Midiprep kit
(Qiagen) and the sequences were veriﬁed using the BigDye
Terminator Cycle Sequencing kit (ABI, Foster City, CA,
USA). For sequencing of hairpin RNA constructs, a
sample denaturation temperature of 988C was used and
1M of Betaine was added in the reaction (27).
The Mfold program (28) was used to determine the
secondary structure of RNA transcripts.
Cellculture andtransfection
The human embryonic kidney (HEK) cell line 293T was
maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Invitrogen, Carlsbad, CA, USA) containing
10% fetal calf serum (FCS), 100 U/ml penicillin, 100 U/
ml streptomycin and minimal essential medium non-
essential amino acids at 378C and 5% CO2. For
luciferase assays, HIV-1 inhibition assays and the
interferon assay, 293T cells were seeded in 24-well
plates at a density of 1.5 10
5 cells per well in 1ml of
DMEM with 10% FCS without antibiotics one day prior
transfection. Transfections were performed using
Lipofectamine 2000 reagent (Invitrogen) according to
the manufacturer’s instructions. For small RNA analysis,
1.6 10
6 293T cells were seeded in T25 ﬂasks. The next
day, the cells were transfected with 5mg of the hairpin
RNA constructs using Lipofectamine 2000 reagent
(Invitrogen) as suggested by the manufacturer.
Luciferase assays
For luciferase assays, cells were co-transfected with 100ng
of ﬁreﬂy luciferase expression plasmid (pGL3; Promega,
Madison, WI, USA), 1ng of renilla luciferase expression
plasmid (pRL-CMV) and diﬀerent amounts of hairpin
RNA expression constructs. pBluescript (pBS) was added
to the transfection mixture to ensure equal DNA amounts.
Transfected cells were lysed at 48h post-transfection in
150ml1   passive lysis buﬀer (Promega) by gentle rocking
for 15min at room temperature. The cell lysates were
centrifuged for 5min at 4000rpm at 48C and 10ml of the
supernatant was used to measure ﬁreﬂy and renilla
luciferase activities with the Dual-Luciferase Reporter
Assay System (Promega). The relative luciferase activity
was calculated as the ratio between the ﬁreﬂy and renilla
luciferase activities and corrected for between-session
variation (29).
HIV-1 inhibition assay
To determine inhibition of virus production, 293T cells
were co-transfected with 250ng of the HIV-1 pLAI, 1ng
pRL-CMV and 2.5, 10 or 25ng of the hairpin RNA
constructs. pBS was added to the transfection mixture to
ensure equal DNA amounts. The cells were grown at 378C
and harvested 48h after transfection. Virus production
was monitored by determining the CA-p24 level in the
culture supernatant by ELISA as described previously
(30). Subsequently, the cells were lysed as described above
and 10ml of the supernatant was used to measure the
renilla luciferase activities using the Renilla Luciferase
Assay System (Promega). The relative CA-p24 production
was calculated as the ratio between the CA-p24 level and
the renilla luciferase activity and corrected for between-
session variation (29).
siRNA detection by northernblotting
Small RNAs were puriﬁed from the transfected 293T cells
at 72h post-transfection using the mirVana miRNA
isolation kit (Ambion) according to the manufacturer’s
instructions. For northern blot analyses, 3mg of small
RNAs was resolved on urea 15% denaturing polyacryl-
amide gels (Invitrogen). For a size reference, we used the
decade RNA molecular weight marker (Ambion, Austin,
TX), which was radioactively labeled and pre-treated as
suggested by the manufacturer. Prior to loading, the
samples were heated for 5min at 958C and immediately
placed on ice. After electrophoresis, the gels were stained
with 2mg/ml ethidium bromide for 20min and destained
with milliQ water for 10min. Then the tRNA bands were
visualized under UV light to check for equal sample
loading. Subsequently, the gels were electrotransferred to
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Mannheim, GmbH, Mannheim, Germany). The RNA
was crosslinked to the membrane under ultraviolet light at
254nm wavelength (1200mJ 100). Labeled LNA oligo-
nucleotides that are complementary to the antisense
strand of the siRNAs pol and nef were used as probes.
Probes were 50 end labeled with the kinaseMax kit
(Ambion) in the presence of 1mlo f[ g-
32]PATP (0.37
MBq/ml, Amersham Biosciences) and puriﬁed using the
Sephadex G-25 spin columns (Amersham Biosciences)
according to manufacturer’s protocol. We used LNA
oligonucleotides 50 ACAGGAGCAGATGATACAG 30
(pol probe) and 50 GGGACTGGAAGGGCTAATT 30
(nef probe). Underlined are the positions that contain
locked nucleic acids. Hybridizations were performed at
428C in 10ml ULTRAhyb hybridization buﬀer (Ambion)
in the presence of the labeled probe, as suggested by the
manufacturer. After hybridization, the membranes were
washed twice for 5min at 428Ci n2 SSC/0.1% SDS and
signals were detected by autoradiography using a phos-
phorimager (Amersham Biosciences).
Interferon assayusing reverse transcriptase-polymerase
chain reaction (RT-PCR)
To determine the induction of the IFN system by the
e-shRNA constructs, 293T cells were transfected with
25ng of e-shRNAs using Lipofectamine 2000 reagent
(Invitrogen). Transfection of 2mg in vitro transcribed
dsRNA was used as a positive control for IFN-b
induction as described previously (16). Total RNA was
isolated from cells 24h post-transfection using RNeasy
mini kit (Invitrogen) according to the manufacturer’s
protocol. Genomic DNA was removed by DNase treat-
ment using the TURBO DNA-free
TM kit (Ambion). First
strand cDNA was reverse transcribed using 1mg of total
RNA, Thermoscript
TM reverse transcriptase (Invitrogen)
and random hexamer primers (Invitrogen).
PCR ampliﬁcation was performed on 2ml RT product
with IFN-b, OAS, MxA, ISG56 and beta actin speciﬁc
primers. The following primer combinations were used:
IFN-b,f :5 0-GATTCATCTAGCACTGGCTGG-30;r :
50-CTTCAGGTAATGCAGAATCC-30 (186bp product)
(31), OAS, f: 50-TCAGAAGAGAAGCCAACGTGA-30;
r: 50-CGGAGACAGCGAGGGTAAAT-30 (399bp pro-
duct) (32), MxA, f: 50-AGTATGGTGTCGACATACC
GGA-30;r :5 0-GAGTCTGGTAAACAGCCGAATG-30
(145bp product) (33), ISG56, f: 50-CTTGAGCCTCCT
TGGGTTCG-30;r :5 0-GCTGATATCTGGGTGCCTA
AGG-30 (137bp product) (33) and b-actin f: 50-GACT
ACCTCATGAAGATCCTCAC-30;r :5 0-ATTGCCAA
TGGTGATGACCTG-30 (197bp product). For PCR
ampliﬁcation, the Reddymix
TM Master Mix (Abgene)
was used in a 50ml reaction. The PCR program was as
follows: 958C for 3min, 30 cycles of 30s at 958C, 30s at
578C, 45s at 728C and a ﬁnal extension for 8min at 728C.
The PCR products were analyzed on a 1.5% agarose
gel. The SmartLadder (Eurogentec) was used as a size
marker.
RESULTS
The position ofan effective siRNA withinan extended
hairpindetermines its activity
In an initial attempt to learn the rules for constructing
multiple siRNAs in a single, extended hairpin, we tested
the importance of the siRNA position within the hairpin
stem. We made a ﬁrst set of three 39bp hairpin RNA
constructs that are expressed from the H1 polymerase III
promoter. These RNA hairpins have identical 5nt loop
sequences and top 2bp of the pSUPER system (6) and end
with a 2nt UU overhang (Figure 1A). We positioned a
highly eﬀective anti-gag siRNA in the base (39B), center
(39C) or top (39T) of the hairpin stem and compared these
with the original 21bp shGag inhibitor (Figure 1A). The
guide/antisense strand of the gag siRNA is boxed in
Figure 1A. This 19nt sequence is ﬂanked in the 39bp
hairpins by contiguous antisense HIV-1 gag sequences.
To determine the inhibitory activities of these hairpin
RNAs, two luciferase reporter constructs were generated.
One reporter contains a broad 50nt gag target sequence
that should reveal the activity of any siRNA processed
from the extended hairpins (Figure 1B, left). The other
reporter contains the minimal 19nt gag target sequence
that only scores the activity of the precise siRNA against
gag (Figure 1B, right). We co-transfected 293T cells with
the luciferase reporter constructs and diﬀerent amounts of
the hairpin RNA constructs. Plasmids encoding renilla
luciferase were included to correct for transfection
variation and to monitor for cell viability that may be
aﬀected by oﬀ-target eﬀects of the encoded siRNAs.
Fireﬂy and renilla luciferase expression was measured 48h
post-transfection and the ratio was used as an indicator
for target inhibition. Luciferase expression in the absence
of inhibitor was set at 100%. Hairpins 39B and 39T were
equally active on the 50nt gag reporter, but hairpin 39C
showed signiﬁcantly less inhibition (Figure 1C, left). All
extended hairpin RNAs clearly showed less inhibition
than shGag. When these constructs were tested on the
luciferase reporter with the exact 19nt gag target, we
observed the same ranking order of activity, but the
diﬀerences are more pronounced (Figure 1C, right).
Construct 39B is most eﬃcient, 39T is marginally active
and 39C did not show any inhibitory eﬀect. These ﬁndings
suggest that processing of the 39bp hairpins starts at the
base of the hairpin RNA transcript, as suggested by the
marginal inhibitory activity of 39T on the 19nt gag
reporter. 39T does have some activity on the broad 50nt
gag reporter because it also detects the siRNAs produced
from the base of 39T. In case of 39C, the centrally located
19nt siRNA is probably destroyed because Dicer cleavage
will occur near the center of the extended hairpin. Again,
some 39C activity is recovered on the 50nt gag reporter,
which likely represents siRNAs processed from the base of
the hairpin.
Designof e-shRNAs encoding twofunctional siRNAs
To study whether eﬃcient inhibition of two genes
can be obtained by a single e-shRNA, we designed
extended hairpin constructs encoding two highly eﬀective
Nucleic Acids Research, 2007, Vol. 35, No. 17 5685siRNAs: one against HIV-1 pol gene (15) and the other
against the nef gene (34). Two versions were made: pol-nef
and nef-pol e-shRNAs (Figure 2A). We extended the
original short hairpin constructs and placed a second
siRNA on top of the ﬁrst siRNA, resulting in a hairpin of
40bp (Figure 2A). Our previous ﬁndings suggest that
processing of 40bp hairpins by Dicer will start at the base
of the hairpin. However, the exact cleavage site of Dicer is
unknown, therefore we made four additional constructs
with increasing length (41–44bp) by insertion of 1–4bp
linkers between the two siRNAs (Figure 2A). The linker
sequences were obtained by extending the sense strand of
the ﬁrst siRNA with HIV-1 derived sequences. This design
allowed us to study the silencing activities of hairpins with
increasing stem length.
To evaluate the suppressive activities of these hairpin
RNA constructs, we co-transfected 293T cells with the
inhibitors and luciferase reporter constructs containing
either the 50nt pol target (Luc-pol) or the 50nt nef target
(Luc-nef) (Figure 2B). The renilla luciferase expression
plasmid was included to control for transfection variation.
Fireﬂy and renilla luciferase expression levels were
measured 48h post-transfection and the ratio in the
presence of pBS was set at 100%. The irrelevant hairpin
RNA construct 39C (against HIV-1 gag) was used as a
negative control. The highest inhibitory activity was
observed for the siRNAs present at the base of the
hairpin. All pol-nef hairpins inhibit the Luc-pol reporter
(Figure 2C, upper left) and all nef-pol hairpins inhibit
the Luc-nef reporter eﬃciently (Figure 2C, lower right).
The activity of the e-shRNAs is comparable to that of the
original shRNAs, although the pol-nef constructs are
slightly less active than shPol (Figure 2C, upper left). Poor
activity was scored for the top siRNAs in the original
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Figure 1. Silencing activities of extended hairpin RNAs depend on the position of the active siRNA in the stem. (A) Schematic of the 39bp extended
hairpin RNAs and the 21bp original shGag. Extended hairpins against gag were constructed with the eﬀective gag siRNA (antisense strand boxed) at
the base (39B), center (39C) and top (39T). (B) Luciferase reporters containing a broad 50nt or a precise 19nt gag target. (C) Reporter constructs
(100ng) and the control renilla luciferase expression plasmid (1ng) were used to co-transfect 293T cells together with diﬀerent amounts of 39bp
extended hairpin RNA constructs and the original shGag. Fireﬂy and renilla luciferase activity was measured 2 days post-transfection and the ratio
was used to calculate the relative luciferase activity. Luciferase activity in the absence of inhibitor was set at 100%. The mean values obtained in
three independent experiments are shown.
5686 Nucleic Acids Research, 2007, Vol. 35, No. 1740bp context, that is nef in the pol-nef construct
(Figure 2C, upper right) and pol in the nef-pol construct
(Figure 2C, lower left). However, addition of spacer
residues improved the activity of these top siRNAs.
The nef siRNA from the pol-nef 43 construct showed
optimal activity that approaches the activity of shNef.
Further size increases (44bp) do not signiﬁcantly enhance
the inhibitory potential. The pol siRNA from the nef-pol
constructs also showed optimal activity when the hairpin
stem length is 43bp. Importantly, increased activity of
the top siRNA is not at the expense of the siRNA at
the base of the hairpin. Thus, a hairpin stem of at least
43bp is required to produce two functional siRNAs from
a single hairpin RNA. Of note, renilla luciferase expres-
sion of the transfection control was not aﬀected by the
extended shRNAs, indicating that the extended hairpins
do not cause cytotoxicity in 293T cells.
Specificity of afunctional e-shRNA
To address the hairpin length requirement from another
perspective, we made two additional mutants in the
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Figure 2. Optimization of a bifunctional extended shRNA. (A) Schematic of the e-shRNAs pol-nef and nef-pol of 40bp and the length variants of
41–44bp. The antisense strand of the siRNAs against pol and nef are marked in blue and green, respectively. (B) Luciferase reporter constructs
containing 50nt HIV-1 pol (Luc-pol) or nef (Luc-nef) sequences, with the 19nt target in the center. (C) 293T cells were co-transfected with 100ng of
the Luc-pol (left) or Luc-nef (right) reporter, 1ng of the renilla luciferase plasmid and 10ng of the e-shRNAs Relative luciferase activities were
determined from the ﬁreﬂy and the control renilla luciferase expression ratios. Luciferase expression in the presence of pBS was set at 100%. The 39C
construct against HIV-1 gag was used as a negative control. The original shPol and shNef were included as positive controls. Averages and standard
deviations represent three independent transfections.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5687nef-pol 44 context. We removed either one or two
nucleotides (Figure 3A, mutant 44-1 and 44-2, respec-
tively) from the passenger/sense pol strand, thus eﬀectively
reducing the number of basepairs by one or two in the
hairpin stem without aﬀecting the guide/antisense strand.
Anti-gag construct 39C was used as a negative control and
we set the luciferase expression in the presence of pBS at
100%. All three constructs showed eﬃcient silencing of
the nef reporter by the siRNAs at the base of the hairpins
(data not shown). However, Luc-pol silencing is sensitive
to the hairpin length. Removal of one nucleotide margin-
ally reduced Luc-pol silencing activity and removal of two
nucleotides showed a signiﬁcant reduction (Figure 3B).
These ﬁndings conﬁrm the results obtained with the
original constructs in that the hairpin stem length is
critical for e-shRNA activity.
To rule out that the silencing activity observed for the
extended shRNAs is due to aspeciﬁc eﬀects, e.g. IFN
induction by the extended hairpins, we made additional
nef-pol 44 variants. If the observed inhibition is due to
RNAi, it should be sequence-speciﬁc. We made three
mutants containing one or two nucleotides deletions in the
guide/antisense pol strand of nef-pol 44 (Figure 3C,
mutant 44a, 44b and 44c). Anti-gag construct 39C was
again used as a negative control and the luciferase
expression with pBS was set at 100%. We observed a
gradual reduction in the ability of the deletion mutants to
silence Luc-pol expression (Figure 3D), but no eﬀect on
Luc-nef silencing was observed (data not shown). These
combined results indicate that the e-shRNA produces two
functional siRNAs that induce RNAi in a sequence-
speciﬁc manner.
Processing ofthe e-shRNA hairpins
We next asked whether the diﬀerences in silencing activity
of the hairpin RNA constructs are due to diﬀerences in
RNA expression, stability or processing into functional
siRNAs. The latter possibility seems most likely as the
siRNA at the base of the hairpin is always active, unlike
the top siRNA. To study this, we transfected 293T cells
with the 40–44 variants of the pol-nef and nef-pol hairpin
constructs and examined siRNA production by northern
blotting. To ensure equal loading of the puriﬁed small
RNA samples on the polyacrylamide gel, we stained the
gel with ethidium bromide to visualize tRNA species and
other small RNA molecules. For detection of siRNAs, we
used 50 end-labeled 19nt LNA probes complementary to
the antisense strand of the siRNAs nef and pol
(Figure 4A). The two individual shRNA constructs were
used as positive control, showing the mature, fully
processed siRNAs. In pol-nef e-shRNA transfected cells,
we readily detected pol siRNAs of  22nt that are derived
from the base of the hairpin (40–44), but nef siRNA
processing from the top of the hairpin increases with
spacer length (Figure 4B). A similar picture was observed
for the nef-pol constructs (Figure 4C). Here, the nef probe
detects an approximately equal amount of the siRNA at
the base of the hairpin, but signiﬁcantly more of the top
siRNA is processed from constructs 42, and especially 43
and 44. These results correlate with the luciferase data in
which we observed stable activity of the siRNA at the base
of the hairpin, but increased activity of the top siRNA
when a 43bp stem length is reached (Figure 2C). Thus,
the increased activity is due to more eﬃcient processing of
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Figure 3. Variants of nef-pol 44 to test the speciﬁcity of the e-shRNA
design. (A) The original nef-pol 44 hairpin and two variants that
contain either a 1 or 2nt deletion (44-1/44-2) in the passenger/sense
strand. These variants have a reduced stem length of 1bp (43bp) or
2bp (42bp). (B) 293T cells were co-transfected with 10ng of the
indicated hairpin constructs, 100ng of the luciferase reporter and 1ng
of the renilla luciferase plasmid. Two days post-transfection, knock-
down eﬃciencies were determined using the ﬁreﬂy and renilla luciferase
expression ratios. (C) Three additional mutant hairpins were made that
contain either one (44a) or two (44b and 44c) deletions in the guide/
antisense strand of the hairpin. (D) 293T cells were co-transfected with
10ng of 44a, 44b and 44c, 100ng of the Luc-pol reporter and 1ng of
the renilla luciferase plasmid. Two days post-transfection, ﬁreﬂy and
renilla luciferase expression was measured and the ratio was used to
determine the relative luciferase activity. Luciferase expression in the
presence of pBS was set at 100%. Averages and standard deviations
represent three independent transfections.
5688 Nucleic Acids Research, 2007, Vol. 35, No. 17the top siRNA. Precursor hairpin RNAs were not
detected in these experiments, suggesting that the
expressed hairpins are eﬃciently processed by the cellular
RNAi machinery. Interestingly, we did not detect the top
part of the hairpin of constructs 40 and 41 that are not
eﬃciently processed into siRNAs. These results indicate
that this part of the e-shRNA is rapidly degraded because
it is not processed and taken up by the RNAi machinery.
Efficient HIV-1 inhibition bye-shRNAs
Next, we tested whether these e-shRNAs are indeed
eﬃcient inhibitors of HIV-1. The target sites for the
encoded pol and nef siRNAs are indicated in the HIV-1
genome (Figure 5A). To quantify the antiviral eﬀects of
these hairpins, we co-transfected the HIV-1 molecular
clone pLAI with an increasing amount of the pol-nef and
nef-pol construct series (40–44) in 293T cells. HIV-1
production was measured by determining CA-p24 levels in
the culture supernatant 2 days post-transfection. CA-p24
levels were normalized to the renilla luciferase activities of
the co-transfected control plasmid. Virus production in
the presence of the empty vector was set at 100%. We
observed optimal inhibition of HIV-1 production by the
pol-nef 42 and 43 and nef-pol 43 constructs (Figure 5B).
These results correlate with the luciferase inhibition
data in Figure 2C and the processing results in
Figure 4B and C.
As an additional control for the sequence-speciﬁcity of
the antiviral e-shRNAs, we constructed two control
hairpin constructs of 43bp. One targets two sites within
the luciferase reporter gene (hLuc) and the other contains
the scrambled sequence of the 43 e-shRNA variant
(hSCR). Neither hLuc nor hSCR inhibited HIV-1
production, indicating that virus suppression by the
e-shRNAs is fully sequence-speciﬁc (Figure 5C).
Towardsuser-friendly e-shRNAs
There are several technical problems associated with the
construction of hairpin RNA expression constructs (35).
First, it is diﬃcult to sequence constructs containing
lengthy inverted repeats. Second, these constructs are
unstable in E. coli, resulting in a high mutation rate in the
hairpin region. We experienced similar problems with
the e-shRNA constructs. We were able to sequence the
constructs using an optimized protocol (988C sample
denaturation and addition of 1M Betaine) (27). We
attempted to modify the hairpins to allow easy cloning
and sequencing, obviously without loss of their silencing
activity. Therefore, we designed variants of the pol-nef
43 hairpin that are less stable, without aﬀecting the guide/
antisense strand of the hairpin RNA. We mutated or
deleted the third nucleotide of the linker in the passenger/
sense strand, which results in hairpins with a destabilizing
mismatch in the central stem regions (Figure 6A). Indeed,
these modiﬁcations allow easier sequencing and improve
the genetic stability of the DNA construct (data not
shown). A regular sequencing protocol can now be used to
sequence these constructs.
Next, we tested the silencing activities of the destabi-
lized hairpins compared to the original pol-nef 43
construct on Luc-pol and Luc-nef reporters. In general,
we observed no signiﬁcant loss of RNAi inhibition on the
pol and nef reporter, although a slight reduction was
observed for the deletion mutant, which creates a 1nt
internal loop (Figure 6B). To test for HIV-1 inhibition, we
co-transfected 293T cells with the pLAI molecular clone,
the renilla expression plasmid and an increasing amount
of the modiﬁed hairpin constructs. All mutant hairpins
showed similar suppression compared to the parental pol-
nef 43 construct, except for the mutant with the 1nt
deletion (Figure 6C). These results indicate that a single
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Figure 4. Northern blot analysis of the e-shRNAs derived siRNAs.
(A) The nef-pol 44 hairpin with the probes to detect siRNAs against
pol and nef. (B) Small RNAs were puriﬁed from 293T cells transfected
with the pol-nef e-shRNA variants 40–44 for detection of siRNAs pol
and nef. pBluescript (pBS), the empty vector (v) and the irrelevant 39C
hairpin against gag (ctr) were used as negative controls. (C) Detection
of siRNAs nef and pol derived from nef-pol e-shRNAs transfected
293T cells. pBS and the irrelevant 39C hairpin against gag (ctr) were
used as negative controls. Ethidium bromide staining of tRNAs serves
as sample loading control. Ethidium bromide stainings were shown for
the upper blot of Figure 4B and C. Stainings were performed for all
northern blots and a similar picture was observed.
Nucleic Acids Research, 2007, Vol. 35, No. 17 56890
20
40
60
80
100
120
C
A
-
p
2
4
/
R
L
U
 
(
%
)
0
20
40
60
80
100
120
C
A
-
p
2
4
/
R
L
U
 
(
%
)
A
B
41 42 43 44 shPol shNef v4 0
41 42 43 44 shPol shNef v4 0
pol-nef
gag
pol
vif
vpr env
tat
rev
vpu 5′ LTR 3′ LTR
nef
C
0
20
40
60
80
100
120
C
A
-
p
2
4
/
R
L
U
 
(
%
)
shPol shNef v hLuc hSCR 43
nef-pol
Figure 5. Inhibition of HIV-1 production by e-shRNA constructs.
(A) The HIV-1 genome and the position of the target sequences for the
e-shRNA derived siRNAs. (B) 293T cells were co-transfected with
250ng of the HIV-1 pLAI, 1ng of renilla luciferase plasmid and 2.5, 10
or 25ng of the e-shRNA constructs. Two days post-transfection,
inhibition of HIV-1 production was determined by measuring CA-p24
levels in the culture supernatant. CA-p24 levels were normalized to the
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renilla luciferase activity in the presence of 25ng of the empty vector (v)
was set at 100%. (C) 293T cells were co-transfected with two control
hairpin constructs. One encodes two siRNAs targeting the luciferase
gene (hLuc) and the other encodes the scrambled sequence of the 43bp
e-shRNA (hSCR). The nef-pol 43bp construct was used as a positive
control. The level of HIV-1 inhibition was determined as described in
B. Averages and standard deviations represent two independent
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Figure 6. Towards user-friendly e-shRNA variants. (A) A mutation or
deletion was introduced in the passenger/sense strand of the pol-nef
43 hairpin, which creates a mismatch in the central stem region.
(B) 293T cells were co-transfected with 10ng of the modiﬁed
e-shRNAs, 100ng of the Luc-pol or Luc-nef and 1ng of the renilla
luciferase plasmid. Two days post-transfection relative luciferase
activities were determined using the ﬁreﬂy and renilla luciferase
expression ratios. Luciferase expression in the presence of pBS was
set at 100%. Averages and standard deviations represent three
independent transfections. (C) Inhibition of HIV-1 production by the
modiﬁed e-shRNAs was determined by co-transfection of 293T cells
with 2.5, 10 or 25ng of the hairpins, 250ng of the HIV-1 pLAI and
1ng of the renilla luciferase plasmid. CA-p24 levels were measured
from the culture supernatant 2 days post-transfection. The ratio
between the CA-p24 and the renilla luciferase activity in the presence
of 25ng of the empty vector (v) was set at 100%. Averages and
standard deviations represent two independent experiments.
5690 Nucleic Acids Research, 2007, Vol. 35, No. 17nucleotide substitution, causing a mismatch in the center
of the e-shRNA, is well-tolerated.
E-shRNAs do not induce theIFN response
Because the IFN response can be induced by long
dsRNAs, we performed extensive RT–PCR analyses for
markers of the IFN response on e-shRNA transfected
293T cells. The expression of the pol-nef e-shRNAs and
the 43bp A mutant (Figure 6A) does not induce the
expression of IFN-b, OAS, MxA and ISG56 mRNAs
(Figure 7). As a positive control, we used in vitro
transcribed long dsRNAs of 300bp. The expression of
long dsRNA resulted in an IFN response in the
transfected cells, showing that 293T cells are able to
activate an innate IFN response.
DISCUSSION
HIV-1 replication can be eﬃciently inhibited via induction
of RNAi using shRNA expressing constructs. However,
HIV-1 can easily escape from RNAi by introducing
mutations or deletions in the target sequence. For eﬀective
inhibition of HIV-1 replication, multiple shRNAs should
be used simultaneously. In addition, highly conserved
sequences within the HIV-1 RNA genome should be
targeted to further reduce the chance of escape. The use of
e-shRNA may be a promising approach to target HIV-1at
multiple sites, but little is known about the design of
eﬀective lhRNAs. In this study, we attempted to explore
some principles for the design of e-shRNAs that encode
two active siRNAs. We ﬁrst constructed extended hairpin
RNAs of 39bp and varied the position of a potent siRNA
in the stem region. We observed that positioning of the
siRNA at the base of the hairpin stem yields optimal
RNAi activity. This observation is consistent with the
proposed model for Dicer action, in which it counts
approximately 22nt from the 30 end of the stem region
to determine the position of cleavage (36,37). Consistent
with this mechanism, Siolas et al. (37) showed that
synthetic 29-mer shRNAs with 30 overhangs were
processed in vitro and in vivo from the 30 end into discrete
products of 21 and 22nt.
Next, we combined two eﬀective siRNAs to build
extended hairpin RNAs of 40–44bp. We demonstrate that
a minimal length of 43bp is needed to generate two
eﬀective siRNAs. In HIV-1 inhibition assays, we observed
an optimal activity when the pol-nef hairpin is 42 or 43bp.
The pol-nef e-shRNA transcripts end with a U and the pol
III promoter terminates after the second U, yielding a
transcript with a 1nt instead of a 2nt 30 overhang. This
may be the cause for the 1nt diﬀerence in length
requirement in the HIV-1 inhibition assays. Indeed,
hairpins with 1nt or 2nt overhangs have diﬀerent Dicer
cleavage sites in vitro, generating siRNA products of
diﬀerent sizes (36). We showed that RNAi activity
observed in luciferase assays correlates with the in vivo
processing data. Importantly, by removal of nucleotides in
the guide/antisense strand of the hairpin RNA, the RNAi
activity of the e-shRNAs is signiﬁcantly impaired,
indicating that the inhibition is sequence-speciﬁc. We
demonstrated that these e-shRNAs profoundly inhibit
HIV-1 replication. Furthermore, we designed user-friendly
e-shRNA variants by introducing destabilizing mutations
to avoid cloning/sequencing problems due to the lengthy
inverted repeat sequences, obviously without loss of
inhibitory capacity. We found similar knockdown eﬃ-
ciencies for the modiﬁed hairpins compared to the original
e-shRNA.
Several studies have demonstrated that multiple siRNA
species can be detected when a lhRNA is expressed in cells
(18,20). However, these studies did not carefully examine
the minimal length requirement of the hairpin to produce
multiple siRNAs. Here, we show that the siRNA at the
base of the hairpin is always active in an e-shRNA, but
activation of the top siRNA requires a minimal stem
length of 43bp. Importantly, the e-shRNA constructs
eﬀectively inhibit two viral genes simultaneously, which
should prevent or delay viral escape.
Previous reports show that inclusion of multiple
mutations within the sense strand, thus creating G-U
basepairs in the hairpin stem, can improve the stability of
the plasmid in E. coli (18,35). Interestingly, it has also
been shown that introduction of G-U bp can avoid the
interferon response (18,19) and improve the suppressive
activity of the hairpin (35). We also observed improved
stability of a plasmid expressing a modiﬁed hairpin with
only a single point mutation in the sense strand that
destabilized the hairpin. Importantly, inclusion of this
point mutation does not reduce the RNAi activity of these
hairpins.
We showed that expression of the e-shRNAs does not
trigger the innate antiviral IFN response. Notably,
cytotoxicity can also be induced by overexpression of
shRNAs, which leads to competition for and oversatura-
tion of endogenous cellular RNAi components (38).
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Figure 7. E-shRNAs do not induce an interferon response. Total RNA
was puriﬁed from 293T cells transfected with the pol-nef e-shRNA
variants 40–44, the 43bp A mutant, the original shRNAs and a 43bp
hairpin encoding the scrambled sequence of the 43bp e-shRNA
(hSCR). The IFN-b, OAS, MxA and ISG56 expression levels were
determined by RT–PCR. b-actin mRNA expression serves as an
internal control. Negative controls include the mock (H2O) transfection
and the PCR reaction on RNA extracts derived from dsRNA
transfected cells that were not subjected to reverse transcription.
In vitro transcribed dsRNA (300bp nef sequences) act as positive
control for IFN-b induction. The 200bp lane of the SmartLadder
(Eurogentec) is shown as a size reference. For the OAS amplicon
product, the 400bp lane of the SmartLadder is shown.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5691This emphasizes the need to use minimal amounts of
shRNA expressing vectors and carefully designed
shRNAs. Therefore, we think it is more eﬀective to
precisely stack potent siRNAs (43bp) instead of using an
extended consecutive sequence. The latter design may
produce moderately active siRNAs that may saturate the
RNAi pathway. Based on our results we suggest that the
use of e-shRNAs with a speciﬁc hairpin length to ensure
proper processing may be beneﬁcial in silencing RNA
viruses in a multi-targeting approach. Furthermore, based
on our data and that of others (18–20,35), we would
advise to introduce multiple point mutations in the sense
strand of the hairpin to avoid the interferon response,
enhance the stability of the plasmid in E. coli and to
facilitate sequencing.
In conclusion, our results provide building principles
for the design of multi-siRNA producing hairpins or
e-shRNAs. We demonstrate that the hairpin stem length is
critical for proper processing and optimal activity. In
addition, expression of the e-shRNAs does not result in
activation of the IFN response. Our e-shRNA constructs
may be an initial step towards the design of further
extended multi-siRNA transcripts. This study stresses the
importance of a careful design of such hairpin RNA
molecules.
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